Bluefin Biomedicine is a startup based in the United States, most recent round Series B.
Bluefin Biomedicine is a company headquartered in the United States. Its most recent tracked round is Series B.
Bluefin develops encryption and tokenization technologies for payment and data security, providing PCI-validated point-to-point encryption and secure data protection solutions for merchants, enterprises, and healthcare organizations globally.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.